Follow the Eris Lifesciences Limited share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares trade on IN IN, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Eris Lifesciences Limited has recorded 44 public disclosures. Market capitalisation: €192.9bn. The latest transaction was disclosed on 18 August 2023 (Sale). Among the most active insiders: Himanshu Jayantbhai Shah. Every trade is free.
44
Insider Decl.
0
Thresholds
€7m
18 ops.
Buy Volume
€9m
26 ops.
Sell Volume
10Σ signal
Buys €7m€9m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 9,501 of 25,791 companies
58.6
score / 100
Value
41
Quality
77
FCF yld1.2%
Earn yld3.1%
EV/EBITDA19.9x
ROE18%
Gross mgn74%
Net mgn20%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.